Opinion|Videos|October 13, 2026

The Adherence Trap with Immediate-Release ADHD Boosters

Immediate-release booster doses ask patients with executive dysfunction to remember, calculate, and decide, often at the worst possible moment. The panel explains why this adherence trap undermines treatment.

This episode, "The Adherence Trap With Immediate-Release ADHD Boosters," looks closely at why an extra dose meant to help patients through the day so often goes untaken.

The panel examines why immediate-release booster doses often fail in practice, since they demand that patients remember a specific time, such as four o'clock, and then decide in the moment whether to take a full dose, a half dose, or delay it. For people whose core symptom is executive dysfunction, this daily calculation becomes its own burden. Once an extended-release dose wears off, patients revert to being distracted and impulsive, which paradoxically makes them less likely to remember the booster meant to correct it. One panelist compares this to a parent who only remembers a forgotten commitment once it is already too late to act on it.

The discussion turns to how clinicians can uncover this pattern through a simple, nonjudgmental question: asking patients which days they actually take their medicine. An answer like "only school days" or "only workdays" opens the door to asking why, which frequently reveals an unspoken side effect or dissatisfaction the patient never volunteered. The panel stresses that adherence alone is not enough to gauge success; providers must also measure how well-treated a patient truly is, since patients who report treatment is "fine" often have no reference point for what optimal control feels like.

To determine whether a patient is optimally treated, the panel recommends anchoring questions to the medication's pharmacokinetic curve, asking what happens between waking and the medicine's onset, and again as it wears off toward evening. Sleep quality deserves particular attention, since insomnia is considered a core feature of ADHD rather than a side issue. The panel favors concrete, granular questions, such as whether a patient finished all their laundry or charting or arrived on time, over vague check-ins that let struggling patients quietly describe their care as fine.

Our next episode, "When to Add a Non-Stimulant for Adult ADHD," brings the panel to a practical question: exactly when does a non-stimulant belong in an adult's treatment plan?

Related to this article